PFM Health Sciences’s Halliburton HAL Stock Holding History

PFM Health Sciences’s Portfolio HAL Stock Details HAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-892,964	Closed	-$40.4M	–	92
2016 Q2	$40.4M	Buy	+892,964	New	+$36.7M	1.22%	39
2015 Q3	–	Sell	-1,084,974	Closed	-$46.7M	–	88
2015 Q2	$46.7M	Buy	1,084,974 +731,745	+207%	+$33.7M	1.18%	35
2015 Q1	$15.5M	Buy	+353,229	New	+$14.7M	0.43%	62
2014 Q4	–	Sell	-1,612,885	Closed	-$104M	–	94
2014 Q3	$104M	Buy	1,612,885 +684,420	+74%	+$46.9M	2.4%	18
2014 Q2	$65.9M	Sell	928,465 -1,506,342	-62%	-$96.5M	1.32%	29
2014 Q1	$143M	Buy	+2,434,807	New	+$130M	2.6%	10

Other funds holding HAL

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PFM Health Sciences's HAL Position: Q3 2016 in Review

PFM Health Sciences sold out of Halliburton (HAL) in Q3 2016, closing a stake of 892,964 shares — an estimated $40.4M sold.

PFM Health Sciences first reported a position in HAL in Q1 2014 and held it in 6 quarters. The position peaked at $143M in Q1 2014. 901 funds tracked by Wall St. Rank hold HAL as of Q3 2016.

PFM Health Sciences reported no remaining Halliburton position as of Q3 2016 after selling out during the quarter.
PFM Health Sciences sold 892,964 Halliburton shares in Q3 2016, an estimated $40.4M.
PFM Health Sciences first reported a position in Halliburton in Q1 2014 and held it in 6 quarters.
PFM Health Sciences's Halliburton position peaked at $143M in Q1 2014.
901 funds tracked by Wall St. Rank held Halliburton as of Q3 2016.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.